Truist raises Pacira stock to buy, price target to $25 from $8
Truist Securities upgraded Pacira Pharmaceuticals (NASDAQ:PCRX) stock rating from Hold to Buy, significantly raising the price target to $25.00 from the previous $8.00. The stock, currently trading at ...
Forbes28d
Truist CD Rates: January 2025
E. Napoletano is a former registered financial advisor and award-winning author and journalist. Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect ...
Winston-Salem Journal17d
Truist discloses abrupt resignation of No. 2 executive Cummins
Truist Financial Corp. disclosed in a regulatory filing Monday the abrupt resignation of Hugh “Beau” Cummins III, its No. 2 executive and a legacy SunTrust Banks Inc. official. Cummins had ...